Who owns CYCLO THERAPEUTICS INC?
- Ticker: CYTH
- CUSIP Number: 23254x201
Tip: Access positions for across all investors
Analyze quarterly positions in Cyclo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Cyclo Therapeutics stock
Who bought or sold CYCLO THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Founders Fund V Management | 481k | $764M | 100% | Dec 2023 |
|
Vanguard Group | 355k | $565k | 26% | Dec 2023 |
|
Founders Fund VI Management | 110k | $175k | 100% | Dec 2023 |
|
Citadel Advisors | 54k | $86k | 282% | Dec 2023 |
|
Wealth Enhancement Advisory Services | 20k | $28k | 10% | Mar 2024 |
|
Wells Fargo & Company | 2.4k | $3.8k | 1% | Dec 2023 |
|
Royal Bank of Canada | 746.00 | $1.0k | 0% | Dec 2023 |
|
Advisor Group Holdings | 600.00 | $954.000000 | 0% | Dec 2023 |
|
Princeton Global Asset Management | 300.00 | $477.000000 | 0% | Dec 2023 |
|
New York State Common Retirement Fund | 113.00 | $0 | 100% | Dec 2023 |
|
Steward Partners Investment Advisory | 90.00 | $143.001000 | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 18.00 | $28.999800 | -92% | Dec 2023 |
|
Bank of America Corporation | 14.00 | $21.999600 | 100% | Dec 2023 |
|
Who sold out of Cyclo Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Virtu Financial | Sep 2023 | 11k | $15k |
Simplex Trading | Dec 2023 | 200.00 | $0 |
UBS Group | Sep 2023 | 88.00 | $125.004000 |